参考文献/References:
[1] ALGHADYAN AA.Diabetic retinopathy an update[J].Saudi J Ophthalmol,2011,25(2):99-111.
[2] FONG DS,FERRIS FL 3rd,DAVIS MD,CHEW EY.Causes of severe visual loss in the early treatment diabetic retinopathy study:ETDRS report number 24.Early Treatment Diabetic Retinopathy Study Research Group[J].Am J Ophthalmol,1999,127(2):137-141.
[3] Early Treatment Diabetic Retinopathy Study Research Group.Fundus photographic risk factors for progression of diabetic retinopathy.ETDRS report number 12[J].Ophthalmology,1991,98(5):823-833.
[4] SRAMEK CK,LEUNG LS,PAULUS YM,PALANKER DV.Therapeutic window of retinal photocoagulation with green(532-nm)and yellow(577-nm) lasers[J].Ophthalmic Surg Lasers Imaging,2012,43(4):341-347.
[5] 张茉莉,田蓓,魏文斌.577、532 nm激光全视网膜激光光凝治疗非增生型糖尿病视网膜病变疗效比较[J].中华眼底病杂志,2016,32(2):135-139.
ZHANG ML,TIAN B,WEI WB.Comparison of 577 nm and 532 nm laser photocoagulation for treatment of non-proliferative diabetic retinopathy[J].Chin J Ocul Fundus Dis,2016,32(2):135-139.
[6] KWON YH,LEE DK,KWON OW.The short-term efficacy of subthreshold micropulse yellow(577-nm) laser photocoagulation for diabetic macular edema[J].Korean J Ophthalmol,2014,28(5):379-385.
[7] WILKINSON CP,FERRIS FL,KLEIN RE,LEE PP,AGARDH CD,DAVIS M,et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1676-1682.
[8] PERENTE I,ALKIN Z,OZKAVA A,DARDABOUNIS D,OGREDEN TA,KONSTANTINIDIS A,et al.Focal laser photocoagulation in non-center involved diabetic macular edema[J].Med Hypothesis Discov Innov Ophthalmol,2014,3(1):9-16.
[9] PALANKER D,BLUMENKRANZ MS.Panretinal photocoagulation for proliferative diabetic retinopathy[J].Am J Ophthalmol,2012,153(4):780-781.
[10] INAGAKI K,OHKOSHI K,OHDE S,DESHPANDE GA,EBIHARA N,MURAKAMI A,et al.Comparative efficacy of pure yellow(577-nm)and 810-nm subthreshold micropulse laser photocoagulation combined with yellow(561-577-nm) direct photocoagulation for diabetic macular edema[J].Jpn J Ophthalmol,2015,59(1):21-28.
[11] FEMAN SS,CHEN J,BURROUGHS,TE.Change in diabetic panretinal photocoagulation incidence[J].Ophthalmic Surg Lasers Imaging,2012,43(4):270-274.
相似文献/References:
[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]陈芳,宁红珠,曾琼英,等.532nm激光光凝治疗视网膜前出血的临床观察[J].眼科新进展,2014,34(5):480.[doi:10.13389/j.cnki.rao.2014.0132]
CHEN Fang,NING Hong-Zhu,ZENG Qiong-Ying,et al.Clinical observation of 532 nm laser photocoagulation for pre-retinal hemorrhage[J].Recent Advances in Ophthalmology,2014,34(9):480.[doi:10.13389/j.cnki.rao.2014.0132]
[12]刘彩霞,谢青,生侠,等.激光光凝术治疗糖尿病视网膜病变时机的选择与治疗效果的相关性研究[J].眼科新进展,2014,34(6):575.[doi:10.13389/j.cnki.rao.2014.0158]